Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratificationBRITISH JOURNAL OF CANCERIF6.82024-03-294OA
P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in NeuroblastomaMOLECULAR & CELLULAR PROTEOMICSIF5.52023-03-015OAAI
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexorJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHIF12.82021-08-1215OAAI
15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor IINTERNATIONAL JOURNAL OF MEDICAL SCIENCESIF3.22021-01-016OAAI
MYT1 attenuates neuroblastoma cell differentiation by interacting with the LSD1/CoREST complexONCOGENEIF7.32020-04-0612PREAI
Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancerONCOLOGY REPORTSIF3.92017-08-2320OAAI